Skip to main contentSkip to navigationSkip to search
ENZY  
SEK  %
Logotype
ENZY  
SEK  %
Logotype

Media

Press releases

2021

November 2, 2021 - Regulatory press release
The long-term plan remains in challenging times
November 2, 2021 - Regulatory press release
Enzymatica Board decides on financial targets
October 18, 2021 - Regulatory press release
Bulletin from the extraordinary general meeting in Enzymatica AB (publ)
September 29, 2021 - Regulatory press release
Notice of extraordinary general meeting in Enzymatica AB (publ)
September 8, 2021 - Non-regulatory press release
Claus Egstrand takes office as CEO ahead of schedule
August 11, 2021 - Non-regulatory press release
Chinese and US patent authorities issue notices of allowance for patent for key component in cold spray ColdZyme
July 16, 2021 - Regulatory press release
Continued lower sales due to pandemic but some stabilization
July 13, 2021 - Regulatory press release
Claus Egstrand appointed new CEO of Enzymatica
July 12, 2021 - Regulatory press release
Enzymatica and STADA extend agreement on ViruProtect to Vietnam
June 22, 2021 - Non-regulatory press release
Enzymatica appoints new Director of Quality Assurance and Communication Manager
June 7, 2021 - Regulatory press release
Enzymatica announces outcome of new rights issue
June 3, 2021 - Non-regulatory press release
Enzymatica launches ColdZyme on Amazon
May 21, 2021 - Non-regulatory press release
Patent for ColdZyme approved in Japan
May 12, 2021 - Regulatory press release
Prospectus for Enzymatica’s rights issue is published
May 5, 2021 - Regulatory press release
Bulletin from Annual General Meeting of Enzymatica AB (publ) on 5 May 2021
April 29, 2021 - Regulatory press release
Lower sales due to the pandemic but new rights issue secures continued international expansion
March 31, 2021 - Regulatory press release
Enzymatica Publication of the Annual Report 2020
March 31, 2021 - Regulatory press release
Notice of Annual General Meeting 2021 in Enzymatica AB (publ)
March 29, 2021 - Regulatory press release
Enzymatica’s Board of Directors decides on a new rights issue of SEK 59.1 million
March 22, 2021 - Regulatory press release
Enzymatica’s sales and result affected by the pandemic
Load more